Concepedia

Publication | Open Access

Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer

71

Citations

27

References

2011

Year

Abstract

The widely used agent ATRA deserves a "second look" in PDAC, but needs to be targeted to patient subsets with biopsy-proven FABP5-negative tumors, or be combined with a chromatin-modifying agent to reexpress endogenous CRABP2.

References

YearCitations

Page 1